Frontier Capital Management CO LLC Viking Therapeutics, Inc. Transaction History
Frontier Capital Management CO LLC
- $8.48 Billion
- Q1 2025
A detailed history of Frontier Capital Management CO LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 417,808 shares of VKTX stock, worth $11.7 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
417,808
Previous 597,739
30.1%
Holding current value
$11.7 Million
Previous $24.1 Million
58.05%
% of portfolio
0.12%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding VKTX
# of Institutions
431Shares Held
65.2MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$286 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$169 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$114 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$87.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$87.7 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...